In Brief: FDA prioritizes inspections, McClellan on J&J board, Unilever told to pull Flora ProActiv ads, NAD reminds firms to support testimonials

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".